Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaewon Kang

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Iscience|April 21, 2023
Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactionsYannic C Bartsch, Deniz Cizmeci, Jaewon Kang, et al.
Disability and Rehabilitation. Assistive Technology|May 31, 2026
Assistive technology devices for enhancing sleep quality: a scoping reviewChang Dae Lee, Desiree Waldeck, Muad Hassan, et al.
Frontiers in Immunology|August 6, 2025
Adenovectored RSV prefusion glycoprotein + soluble glycoprotein combination immunization establishes persistent opsonophagocytic antibody response through IgG3Xin Tong, Ross Blanc, Deniz Cizmeci, et al.
Pediatric Research|May 12, 2023
Long-term humoral signatures following acute pediatric COVID-19 and Multisystem Inflammatory Syndrome in ChildrenMadeleine D Burns, Yannic C Bartsch, Jameson P Davis, et al.
NPJ Vaccines|December 3, 2022
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in childrenYannic C Bartsch, Jessica W Chen, Jaewon Kang, et al.
Science Translational Medicine|March 15, 2022
Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccinesYannic C Bartsch, Xin Tong, Jaewon Kang, et al.
Cell|December 13, 2022
Antibody effector functions are associated with protection from respiratory syncytial virusYannic C Bartsch, Deniz Cizmeci, Jaewon Kang, et al.
Immunity|January 29, 2022
mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concernPaulina Kaplonek, Stephanie Fischinger, Deniz Cizmeci, et al.
Cell Reports. Medicine|November 9, 2022
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapyJonathan D Herman, Chuangqi Wang, John Stephen Burke, et al.
Frontiers in Oncology|February 11, 2026
Case Report: Prolonged response to cabozantinib and pembrolizumab in treatment-refractory metastatic pancreatic ductal adenocarcinomaAnna M Reagan, Hannah G McDonald, Jaewon Kang, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Iscience|April 21, 2023
Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactionsYannic C Bartsch, Deniz Cizmeci, Jaewon Kang, et al.
Disability and Rehabilitation. Assistive Technology|May 31, 2026
Assistive technology devices for enhancing sleep quality: a scoping reviewChang Dae Lee, Desiree Waldeck, Muad Hassan, et al.
Frontiers in Immunology|August 6, 2025
Adenovectored RSV prefusion glycoprotein + soluble glycoprotein combination immunization establishes persistent opsonophagocytic antibody response through IgG3Xin Tong, Ross Blanc, Deniz Cizmeci, et al.
Pediatric Research|May 12, 2023
Long-term humoral signatures following acute pediatric COVID-19 and Multisystem Inflammatory Syndrome in ChildrenMadeleine D Burns, Yannic C Bartsch, Jameson P Davis, et al.
NPJ Vaccines|December 3, 2022
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in childrenYannic C Bartsch, Jessica W Chen, Jaewon Kang, et al.
Science Translational Medicine|March 15, 2022
Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccinesYannic C Bartsch, Xin Tong, Jaewon Kang, et al.
Cell|December 13, 2022
Antibody effector functions are associated with protection from respiratory syncytial virusYannic C Bartsch, Deniz Cizmeci, Jaewon Kang, et al.
Immunity|January 29, 2022
mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concernPaulina Kaplonek, Stephanie Fischinger, Deniz Cizmeci, et al.
Cell Reports. Medicine|November 9, 2022
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapyJonathan D Herman, Chuangqi Wang, John Stephen Burke, et al.
Frontiers in Oncology|February 11, 2026
Case Report: Prolonged response to cabozantinib and pembrolizumab in treatment-refractory metastatic pancreatic ductal adenocarcinomaAnna M Reagan, Hannah G McDonald, Jaewon Kang, et al.
Pageof 3